Scholar Rock (SRRK)
(Delayed Data from NSDQ)
$31.96 USD
+0.56 (1.78%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $31.95 -0.01 (-0.02%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SRRK 31.96 +0.56(1.78%)
Will SRRK be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SRRK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SRRK
Should You Buy Scholar Rock Holding Corporation (SRRK) After Golden Cross?
SRRK Stock Soars as Muscle Disease Drug Meets Phase III Study Goal
SRRK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for SRRK
Scholar Rock Holding (SRRK) Sees Price Target Revision by BMO Capital | SRRK Stock News
Decoding Scholar Rock Holding Corp (SRRK): A Strategic SWOT Insight
Q2 2025 Scholar Rock Holding Corp Earnings Call Transcript
SRRK Crosses Below Key Moving Average Level
Scholar Rock outlines Q3 2025 U.S. apitegromab launch plans amid regulatory progress and global expansion focus